| 66.6 1.29 (1.98%) | 05-11 13:52 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 77.98  |
1-year : | 91.08 |
| Resists | First : | 66.76 |
Second : | 77.98 |
| Pivot price | 57.74 |
|||
| Supports | First : | 53.24 |
Second : | 44.88 |
| MAs | MA(5) : | 63.63 |
MA(20) : | 56.45 |
| MA(100) : | 47.86 |
MA(250) : | 38.74 |
|
| MACD | MACD : | 3.9 |
Signal : | 2.9 |
| %K %D | K(14,3) : | 94.5 |
D(3) : | 94.2 |
| RSI | RSI(14): 79.8 |
|||
| 52-week | High : | 66.76 | Low : | 26.35 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ EMEQ ] has closed below upper band by 2.1%. Bollinger Bands are 162.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 65.4 - 65.66 | 65.66 - 65.89 |
| Low: | 63.42 - 63.74 | 63.74 - 64.02 |
| Close: | 64.75 - 65.28 | 65.28 - 65.73 |
Seeks to invest in competitively advantaged companies that are well positioned to capture long-term secular growth opportunities. An actively managed portfolio of 35-60 stocks seeking to capitalize on high-conviction investment ideas.
Thu, 16 Apr 2026
EMEQ Vs DVYE: Choosing Growth Or Resilience In Emerging Market ETFs (NASDAQ:EMEQ) - Seeking Alpha
Fri, 13 Mar 2026
Kroger Shares Rise, Pharmacies Add Eli Lilly Zepbound KwikPen - Kroger (NYSE:KR), Eli Lilly (NYSE:LLY) - Benzinga
Mon, 24 Nov 2025
The highest-rated non-U.S. ETFs to consider now (DXJ:NYSEARCA) - Seeking Alpha
Thu, 05 Jun 2025
Active EM ETF Offers Access to a Time-Tested Strategy - Advisor Perspectives
Wed, 12 Feb 2025
EMEQ Stock Price, Quote & Chart | NOMURA FOCUSED EMERGING MARK (NASDAQ:EMEQ) - ChartMill
Sat, 08 Feb 2025
The Case for Emerging Markets - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|